🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: * The National Cancer Institute (NCI) Surgery Branch has devel...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2013-12-12
Trial ID
NCT01993719
The purpose of this Pilot Study is to investigate the safety, side effects,...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2016-03-08
Trial ID
NCT02652455
To determine the feasibility and safety of administering a regimen of TIL/I...
Status
Terminated
Location
Yale New Haven Hospital
Start Date
2018-02-06
Trial ID
NCT03526185
Treatments Being Tested
This study is to investigate safety and feasibility of a combination therap...
Status
Completed
Location
Division of Medical Oncology and Cancer Immunology, University Hospital Basel
Start Date
2020-09-17
Trial ID
NCT04165967
Treatments Being Tested
To improve the efficacy of immunotherapy for cancer, recent studies focused...
Status
Unknown
Location
Nantes University Hospital
Start Date
2018-02-12
Trial ID
NCT03374839
Treatments Being Tested
This is a single center, single arm phase I trial to test the feasibility a...
Status
Completed
Location
CHUV Oncology Department
Start Date
2018-02-21
Trial ID
NCT03475134
Treatments Being Tested
Investigators plan to study the safety, side effects, and benefits of tumor...
Status
Completed
Location
University of Florida Health Cancer Center.
Start Date
2017-10-11
Trial ID
NCT03215810
To determine the effect of a special preparation of cells, called tumor-inf...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2023-03-10
Trial ID
NCT05681780
This phase II trial studies how well autologous tumor infiltrating lymphocy...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-04-27
Trial ID
NCT03449108
Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) in c...
Status
Unknown
Location
Sheba Medical Center
Start Date
2017-06-05
Trial ID
NCT03166397
Treatments Being Tested